0000950123-16-018588.txt : 20160728
0000950123-16-018588.hdr.sgml : 20160728
20160728161825
ACCESSION NUMBER: 0000950123-16-018588
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20160630
FILED AS OF DATE: 20160728
DATE AS OF CHANGE: 20160728
EFFECTIVENESS DATE: 20160728
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Polaris Venture Management Co. V, L.L.C.
CENTRAL INDEX KEY: 0001439589
IRS NUMBER: 204234752
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-16125
FILM NUMBER: 161790364
BUSINESS ADDRESS:
STREET 1: ONE MARINA PARK DRIVE
STREET 2: 10TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 781-290-0770
MAIL ADDRESS:
STREET 1: ONE MARINA PARK DRIVE
STREET 2: 10TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
true
false
0001439589
XXXXXXXX
06-30-2016
06-30-2016
Polaris Venture Management Co. V, L.L.C.
ONE MARINA PARK DRIVE
10TH FLOOR
BOSTON
MA
02210
13F HOLDINGS REPORT
028-16125
N
Mary Blair
Authorized Signatory
855-787-3500
/s/ Mary Blair
Boston
MA
07-27-2016
0
10
93152
false
INFORMATION TABLE
2
form13fInfoTable.xml
INFORMATION TABLE FOR FORM 13F
Bind Therapeutics, Inc.
Common Stock
05548N107
789
2018253
SH
SOLE
2018253
0
0
Fate Therapeutics, Inc.
Common Stock
31189P102
4204
2473186
SH
SOLE
2473186
0
0
Genocea Biosciences, Inc.
Common Stock
372427104
8071
1968606
SH
SOLE
1968606
0
0
Trevena, Inc.
Common Stock
89532E109
14303
2270319
SH
SOLE
2270319
0
0
Cerulean Pharma Inc
Common Stock
15708Q105
6970
3287529
SH
SOLE
3287529
0
0
Ocular Therapeutix, Inc.
Common Stock
67576A100
4944
998713
SH
SOLE
998713
0
0
T2 Biosystems, Inc.
Common Stock
89853L104
14798
1875524
SH
SOLE
1875524
0
0
Atyr Pharma Inc.
Common Stock
002120103
5082
1827992
SH
SOLE
1827992
0
0
Pulmatrix Inc.
Common Stock
74584P103
7072
3607996
SH
SOLE
3607996
0
0
Selecta Biosciences, Inc.
Common Stock
816212104
26919
1924151
SH
SOLE
1924151
0
0